Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

SELL
$7.45 - $12.32 $117,978 - $195,099
-15,836 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$13.68 - $20.46 $1,887 - $2,823
-138 Reduced 0.86%
15,836 $254,000
Q1 2020

May 11, 2020

SELL
$14.83 - $26.72 $3,618 - $6,519
-244 Reduced 1.5%
15,974 $248,000
Q4 2019

Feb 13, 2020

SELL
$9.77 - $24.6 $4,054 - $10,209
-415 Reduced 2.5%
16,218 $399,000
Q3 2019

Nov 12, 2019

SELL
$10.17 - $13.86 $1,454 - $1,981
-143 Reduced 0.85%
16,633 $172,000
Q2 2019

Aug 12, 2019

SELL
$11.43 - $15.12 $4,389 - $5,806
-384 Reduced 2.24%
16,776 $211,000
Q4 2018

Feb 13, 2019

SELL
$5.22 - $10.44 $7,830 - $15,660
-1,500 Reduced 8.04%
17,160 $106,000
Q3 2018

Nov 13, 2018

BUY
$9.5 - $13.75 $177,270 - $256,575
18,660 New
18,660 $198,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.